Creative Biogene, a biotechnology products and services provider, announced the release of its GMP-grade mRNA production services to advance the project development process and research in various fields.

“With one-stop GMP mRNA synthesis service, including the whole process from mRNA design, synthesis to mRNA stock solution detection, strict quality assurance and quality control, we can provide customers with satisfactory and professional services,” said Marcia Brady, the marketing director of Creative Biogene. “We are always dedicated to providing customized molecular biology reagents and professional technical services for customers in the field of life science research.”

Combining a powerful technology platform, advanced cGMP-grade production facilities, and rich experience in mRNA synthesis, Creative Biogene provides global customers with GMP-grade mRNA production services to meet different project needs. Creative Biogene provides GMP-grade mRNA production services to help clients progress in project development and research in mRNA vaccines, cell therapies, gene editing, protein replacement, and antibodies.

Creative Biogene provides customers with a one-stop solution for GMP-grade mRNA production from research to clinical trials, starting with DNA template design and mRNA sequence synthesis. Creative Biogene’s customizable production process can meet different customer needs, provide high-quality mRNA that meets standards and can provide quantities from milligrams to multigrams.

The company can design and optimize mRNA sequences according to needs and provide de novo design and production services for GMP-grade plasmid production and linearized template preparation.